Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for its new prevention drug Yeztugo, helping to boost its profit. Overall product ...
COVID triples the risk of a heart attack, researchers say, while flu quadruples the risk. Shingles, HIV, and hepatitis C ...
More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...
Researchers used cryo-EM to study how the HIV enzyme integrase arranges in 3D to slip its DNA into the host genome and pack ...
Viral infections are associated with an increased risk of cardiovascular disease, including coronary heart disease and stroke.